US Stock MarketDetailed Quotes

ARWR Arrowhead Pharmaceuticals

Watchlist
  • 20.060
  • +0.570+2.92%
Close Nov 4 16:00 ET
  • 20.060
  • 0.0000.00%
Post 16:03 ET
2.49BMarket Cap-4313P/E (TTM)

Arrowhead Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Jun 30, 2024
(Q2)Mar 31, 2024
(Q1)Dec 31, 2023
(FY)Sep 30, 2023
(Q4)Sep 30, 2023
(Q3)Jun 30, 2023
(Q2)Mar 31, 2023
(Q1)Dec 31, 2022
(FY)Sep 30, 2022
(Q4)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-455.51%-115.42M
-191.68%-92.38M
-56.05%-117.84M
-13.05%-153.89M
62.28%-25.93M
69.81%-20.78M
-150.49%-31.67M
-23.17%-75.52M
-179.46%-136.13M
-186.06%-68.74M
Net income from continuing operations
-67.08%-173.98M
-366.37%-127M
-223.78%-135.38M
-18.57%-209.28M
-29.17%-111.02M
-44.53%-104.13M
7.46%47.68M
33.50%-41.81M
-25.31%-176.49M
-35.61%-85.94M
Operating gains losses
--0
--0
---80K
----
----
----
----
----
359.48%4.43M
----
Depreciation and amortization
45.97%4.78M
69.54%4.53M
58.53%4.26M
19.88%12.49M
45.08%3.86M
26.29%3.28M
2.89%2.67M
4.51%2.69M
26.06%10.42M
6.23%2.66M
Other non cash items
-1.26%5.09M
43.27%7.25M
88.38%5.37M
--18.33M
--5.26M
206.29%5.16M
730.38%5.06M
1,117.50%2.85M
----
----
Change In working capital
-55.93%24.64M
103.15%3.37M
81.67%-10.87M
47.56%-51.55M
513.17%58.77M
239.12%55.92M
-473.48%-106.91M
-135.10%-59.32M
-142.99%-98.29M
-688.78%-14.23M
-Change in receivables
--0
--0
--0
-84.06%1.41M
206.40%1.25M
6,225.42%68.19M
-2,459.30%-29.87M
-477.61%-38.16M
194.01%8.85M
87.78%-1.17M
-Change in prepaid assets
-88.20%897K
-109.15%-895K
-116.60%-1.75M
160.15%11.6M
-56.47%-16.31M
236.91%7.6M
441.60%9.78M
2,439.78%10.53M
-5,258.61%-19.29M
-511.20%-10.42M
-Change in payables and accrued expense
474.18%24.28M
132.18%3.64M
-29.97%-12.06M
61.57%18.03M
246.74%45.11M
3.06%-6.49M
-190.35%-11.32M
-20.78%-9.28M
-8.14%11.16M
374.49%13.01M
-Change in other current liabilities
----
----
579.07%3.8M
----
----
----
----
143.04%559K
----
----
-Change in other working capital
70.97%-4.42M
105.89%4.42M
96.23%-866K
16.58%-82.59M
295.33%30.55M
46.51%-15.21M
-172.68%-74.95M
16.25%-22.98M
-143.75%-99.01M
-210.12%-15.64M
Cash from discontinued investing activities
Operating cash flow
-455.51%-115.42M
-191.68%-92.38M
-56.05%-117.84M
-13.05%-153.89M
62.28%-25.93M
69.81%-20.78M
-150.49%-31.67M
-23.17%-75.52M
-179.46%-136.13M
-186.06%-68.74M
Investing cash flow
Cash flow from continuing investing activities
170.16%6.95M
-645.70%-268.94M
180.35%64.84M
-1,675.06%-96.16M
-16.29%30.51M
-116.16%-9.91M
48.30%-36.07M
-141.71%-80.69M
96.18%-5.42M
130.82%36.45M
Net PPE purchase and sale
69.00%-14.45M
-24.75%-34.08M
-76.44%-68.66M
-234.88%-176.74M
-95.37%-63.91M
-388.73%-46.61M
-474.79%-27.31M
-573.43%-38.91M
-123.94%-52.78M
-298.96%-32.71M
Net investment purchase and sale
-41.69%21.4M
-2,583.83%-234.86M
419.50%133.5M
70.15%80.58M
36.53%94.42M
-48.17%36.7M
86.54%-8.75M
-51.35%-41.78M
140.10%47.36M
162.84%69.16M
Cash from discontinued investing activities
Investing cash flow
170.16%6.95M
-645.70%-268.94M
180.35%64.84M
-1,675.06%-96.16M
-16.29%30.51M
-116.16%-9.91M
48.30%-36.07M
-141.71%-80.69M
96.18%-5.42M
130.82%36.45M
Financing cash flow
Cash flow from continuing financing activities
4,335.48%50.39M
82,741.73%430.78M
-99.89%267K
288.20%253.05M
-3.98%821K
-98.13%1.14M
-71.83%520K
13,193.16%250.58M
476.61%65.19M
4.91%855K
Net common stock issuance
--0
----
----
----
----
--0
----
----
----
----
Proceeds from stock option exercised by employees
-65.93%387K
190.77%1.51M
-53.65%267K
-41.13%3.05M
-3.98%821K
89.33%1.14M
-71.83%520K
-69.44%576K
-54.13%5.19M
4.91%855K
Net other financing activities
----
----
----
316.67%250M
--0
--0
--0
--250M
--60M
--0
Cash from discontinued financing activities
Financing cash flow
4,335.48%50.39M
82,741.73%430.78M
-99.89%267K
288.20%253.05M
-3.98%821K
-98.13%1.14M
-71.83%520K
13,193.16%250.58M
476.61%65.19M
4.91%855K
Net cash flow
Beginning cash position
-5.38%127.7M
-71.22%58.22M
2.67%110.89M
-41.44%108.01M
-24.46%105.33M
56.19%134.96M
120.83%202.25M
-41.44%108.01M
28.45%184.43M
-57.22%139.44M
Current changes in cash
-96.58%-58.08M
203.34%69.46M
-155.88%-52.73M
103.94%3.01M
117.19%5.4M
-155.68%-29.55M
-1,197.61%-67.22M
201.68%94.37M
-286.53%-76.36M
77.78%-31.44M
Effect of exchange rate changes
-182.28%-223K
135.14%26K
147.54%58K
-82.09%-122K
5,000.00%153K
-146.88%-79K
-7,500.00%-74K
-212.82%-122K
23.86%-67K
--3K
End cash Position
-34.12%69.4M
-5.38%127.7M
-71.22%58.22M
2.67%110.89M
2.67%110.89M
-24.46%105.33M
56.19%134.96M
120.83%202.25M
-41.44%108.01M
-41.44%108.01M
Free cash flow
-92.73%-129.87M
-114.38%-126.45M
-62.98%-186.5M
-75.02%-330.63M
11.45%-89.83M
14.00%-67.38M
-201.74%-58.99M
-70.57%-114.43M
-227.86%-188.91M
-214.78%-101.45M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Jun 30, 2024(Q2)Mar 31, 2024(Q1)Dec 31, 2023(FY)Sep 30, 2023(Q4)Sep 30, 2023(Q3)Jun 30, 2023(Q2)Mar 31, 2023(Q1)Dec 31, 2022(FY)Sep 30, 2022(Q4)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -455.51%-115.42M-191.68%-92.38M-56.05%-117.84M-13.05%-153.89M62.28%-25.93M69.81%-20.78M-150.49%-31.67M-23.17%-75.52M-179.46%-136.13M-186.06%-68.74M
Net income from continuing operations -67.08%-173.98M-366.37%-127M-223.78%-135.38M-18.57%-209.28M-29.17%-111.02M-44.53%-104.13M7.46%47.68M33.50%-41.81M-25.31%-176.49M-35.61%-85.94M
Operating gains losses --0--0---80K--------------------359.48%4.43M----
Depreciation and amortization 45.97%4.78M69.54%4.53M58.53%4.26M19.88%12.49M45.08%3.86M26.29%3.28M2.89%2.67M4.51%2.69M26.06%10.42M6.23%2.66M
Other non cash items -1.26%5.09M43.27%7.25M88.38%5.37M--18.33M--5.26M206.29%5.16M730.38%5.06M1,117.50%2.85M--------
Change In working capital -55.93%24.64M103.15%3.37M81.67%-10.87M47.56%-51.55M513.17%58.77M239.12%55.92M-473.48%-106.91M-135.10%-59.32M-142.99%-98.29M-688.78%-14.23M
-Change in receivables --0--0--0-84.06%1.41M206.40%1.25M6,225.42%68.19M-2,459.30%-29.87M-477.61%-38.16M194.01%8.85M87.78%-1.17M
-Change in prepaid assets -88.20%897K-109.15%-895K-116.60%-1.75M160.15%11.6M-56.47%-16.31M236.91%7.6M441.60%9.78M2,439.78%10.53M-5,258.61%-19.29M-511.20%-10.42M
-Change in payables and accrued expense 474.18%24.28M132.18%3.64M-29.97%-12.06M61.57%18.03M246.74%45.11M3.06%-6.49M-190.35%-11.32M-20.78%-9.28M-8.14%11.16M374.49%13.01M
-Change in other current liabilities --------579.07%3.8M----------------143.04%559K--------
-Change in other working capital 70.97%-4.42M105.89%4.42M96.23%-866K16.58%-82.59M295.33%30.55M46.51%-15.21M-172.68%-74.95M16.25%-22.98M-143.75%-99.01M-210.12%-15.64M
Cash from discontinued investing activities
Operating cash flow -455.51%-115.42M-191.68%-92.38M-56.05%-117.84M-13.05%-153.89M62.28%-25.93M69.81%-20.78M-150.49%-31.67M-23.17%-75.52M-179.46%-136.13M-186.06%-68.74M
Investing cash flow
Cash flow from continuing investing activities 170.16%6.95M-645.70%-268.94M180.35%64.84M-1,675.06%-96.16M-16.29%30.51M-116.16%-9.91M48.30%-36.07M-141.71%-80.69M96.18%-5.42M130.82%36.45M
Net PPE purchase and sale 69.00%-14.45M-24.75%-34.08M-76.44%-68.66M-234.88%-176.74M-95.37%-63.91M-388.73%-46.61M-474.79%-27.31M-573.43%-38.91M-123.94%-52.78M-298.96%-32.71M
Net investment purchase and sale -41.69%21.4M-2,583.83%-234.86M419.50%133.5M70.15%80.58M36.53%94.42M-48.17%36.7M86.54%-8.75M-51.35%-41.78M140.10%47.36M162.84%69.16M
Cash from discontinued investing activities
Investing cash flow 170.16%6.95M-645.70%-268.94M180.35%64.84M-1,675.06%-96.16M-16.29%30.51M-116.16%-9.91M48.30%-36.07M-141.71%-80.69M96.18%-5.42M130.82%36.45M
Financing cash flow
Cash flow from continuing financing activities 4,335.48%50.39M82,741.73%430.78M-99.89%267K288.20%253.05M-3.98%821K-98.13%1.14M-71.83%520K13,193.16%250.58M476.61%65.19M4.91%855K
Net common stock issuance --0------------------0----------------
Proceeds from stock option exercised by employees -65.93%387K190.77%1.51M-53.65%267K-41.13%3.05M-3.98%821K89.33%1.14M-71.83%520K-69.44%576K-54.13%5.19M4.91%855K
Net other financing activities ------------316.67%250M--0--0--0--250M--60M--0
Cash from discontinued financing activities
Financing cash flow 4,335.48%50.39M82,741.73%430.78M-99.89%267K288.20%253.05M-3.98%821K-98.13%1.14M-71.83%520K13,193.16%250.58M476.61%65.19M4.91%855K
Net cash flow
Beginning cash position -5.38%127.7M-71.22%58.22M2.67%110.89M-41.44%108.01M-24.46%105.33M56.19%134.96M120.83%202.25M-41.44%108.01M28.45%184.43M-57.22%139.44M
Current changes in cash -96.58%-58.08M203.34%69.46M-155.88%-52.73M103.94%3.01M117.19%5.4M-155.68%-29.55M-1,197.61%-67.22M201.68%94.37M-286.53%-76.36M77.78%-31.44M
Effect of exchange rate changes -182.28%-223K135.14%26K147.54%58K-82.09%-122K5,000.00%153K-146.88%-79K-7,500.00%-74K-212.82%-122K23.86%-67K--3K
End cash Position -34.12%69.4M-5.38%127.7M-71.22%58.22M2.67%110.89M2.67%110.89M-24.46%105.33M56.19%134.96M120.83%202.25M-41.44%108.01M-41.44%108.01M
Free cash flow -92.73%-129.87M-114.38%-126.45M-62.98%-186.5M-75.02%-330.63M11.45%-89.83M14.00%-67.38M-201.74%-58.99M-70.57%-114.43M-227.86%-188.91M-214.78%-101.45M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data